
|Articles|February 1, 2002
Daptomycin impressive against dual staph, strep skin infections
Chicago - Daptomycin (Cidecin), a novel lipopeptide antibiotic, showed a trend toward an improved clinical response compared to current standard therapy in the treatment of complicated skin and soft tissue (cSST) infections caused by dual infection with
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease
5


















